JP2014501778A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014501778A5 JP2014501778A5 JP2013548446A JP2013548446A JP2014501778A5 JP 2014501778 A5 JP2014501778 A5 JP 2014501778A5 JP 2013548446 A JP2013548446 A JP 2013548446A JP 2013548446 A JP2013548446 A JP 2013548446A JP 2014501778 A5 JP2014501778 A5 JP 2014501778A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- cell
- composition according
- group
- accs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 11
- 102000004127 Cytokines Human genes 0.000 claims 4
- 108090000695 Cytokines Proteins 0.000 claims 4
- 208000000491 Tendinopathy Diseases 0.000 claims 3
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 claims 2
- 206010043255 Tendonitis Diseases 0.000 claims 2
- 208000026062 Tissue disease Diseases 0.000 claims 2
- 239000013543 active substance Substances 0.000 claims 2
- 210000001691 amnion Anatomy 0.000 claims 2
- 239000013592 cell lysate Substances 0.000 claims 2
- 239000003636 conditioned culture medium Substances 0.000 claims 2
- 210000002808 connective tissue Anatomy 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 201000004415 tendinitis Diseases 0.000 claims 2
- 208000037816 tissue injury Diseases 0.000 claims 2
- 238000011282 treatment Methods 0.000 claims 2
- 206010006811 Bursitis Diseases 0.000 claims 1
- 102000019034 Chemokines Human genes 0.000 claims 1
- 108010012236 Chemokines Proteins 0.000 claims 1
- 208000034656 Contusions Diseases 0.000 claims 1
- 208000034693 Laceration Diseases 0.000 claims 1
- 206010040844 Skin exfoliation Diseases 0.000 claims 1
- 208000010040 Sprains and Strains Diseases 0.000 claims 1
- 208000013201 Stress fracture Diseases 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- -1 antibodies Substances 0.000 claims 1
- 229940121375 antifungal agent Drugs 0.000 claims 1
- 239000003429 antifungal agent Substances 0.000 claims 1
- 239000003443 antiviral agent Substances 0.000 claims 1
- 230000001413 cellular effect Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000006835 compression Effects 0.000 claims 1
- 238000007906 compression Methods 0.000 claims 1
- 230000009519 contusion Effects 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000009207 exercise therapy Methods 0.000 claims 1
- 238000004299 exfoliation Methods 0.000 claims 1
- 239000003102 growth factor Substances 0.000 claims 1
- 230000035876 healing Effects 0.000 claims 1
- 229960003444 immunosuppressant agent Drugs 0.000 claims 1
- 239000003018 immunosuppressive agent Substances 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 229960004857 mitomycin Drugs 0.000 claims 1
- 238000000554 physical therapy Methods 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 230000003248 secreting effect Effects 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 238000013268 sustained release Methods 0.000 claims 1
- 239000012730 sustained-release form Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161460913P | 2011-01-10 | 2011-01-10 | |
| US61/460,913 | 2011-01-10 | ||
| PCT/US2012/000017 WO2012096796A1 (en) | 2011-01-10 | 2012-01-07 | Methods for accelerating the healing of connective tissue injuries and disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014501778A JP2014501778A (ja) | 2014-01-23 |
| JP2014501778A5 true JP2014501778A5 (https=) | 2014-12-25 |
| JP6041812B2 JP6041812B2 (ja) | 2016-12-14 |
Family
ID=46455423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013548446A Active JP6041812B2 (ja) | 2011-01-10 | 2012-01-07 | 結合組織の損傷および障害の治癒を促進する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US8642547B2 (https=) |
| EP (1) | EP2663637B1 (https=) |
| JP (1) | JP6041812B2 (https=) |
| CN (1) | CN103298927B (https=) |
| CA (1) | CA2823689C (https=) |
| ES (1) | ES2646438T3 (https=) |
| WO (1) | WO2012096796A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017520517A (ja) * | 2014-05-08 | 2017-07-27 | ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド | 持続放出性血管新生調節組成物ならびに血管新生を誘導および調節する方法 |
| WO2018123628A1 (ja) * | 2016-12-28 | 2018-07-05 | ロート製薬株式会社 | 細胞医薬組成物、疾患治療用キット及び細胞懸濁用溶液 |
| BR112022000502A2 (pt) * | 2019-08-09 | 2022-03-15 | Axolotl Biologix Inc | Método para preparar uma composição derivada de âmnion humano acelular configurada para uso terapêutico, método para tratar um sujeito sofrendo de doença articular degenerativa, e composição derivada de âmnion humano |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8803697D0 (en) * | 1988-02-17 | 1988-03-16 | Deltanine Research Ltd | Clinical developments using amniotic membrane cells |
| EP0896825B1 (en) * | 1997-08-14 | 2002-07-17 | Sulzer Innotec Ag | Composition and device for in vivo cartilage repair comprising nanocapsules with osteoinductive and/or chondroinductive factors |
| EP2316919B1 (en) * | 2001-02-14 | 2015-10-07 | Anthrogenesis Corporation | Post-partum mammalian placenta, its use and placental stem cells therefrom |
| GB0113697D0 (en) * | 2001-06-06 | 2001-07-25 | Smith & Nephew | Fixation devices for tissue repair |
| US7473816B2 (en) * | 2004-05-18 | 2009-01-06 | Lohmann & Rauscher, Inc. | Multilayer moisture management fabric |
| US20060222634A1 (en) | 2005-03-31 | 2006-10-05 | Clarke Diana L | Amnion-derived cell compositions, methods of making and uses thereof |
| US8153430B2 (en) * | 2005-03-31 | 2012-04-10 | Stemnion, Inc. | Methods related to surgery |
| EP1981971A4 (en) | 2006-01-11 | 2009-08-12 | Technion Res & Dev Foundation | PROGENITORS OF CONNECTIVE TISSUES OBTAINED FROM ADULT STEM CELLS FOR TISSUE GENE |
| US8871198B2 (en) * | 2006-03-29 | 2014-10-28 | Stemnion, Inc. | Methods related to wound healing |
| US8475788B2 (en) * | 2006-06-14 | 2013-07-02 | Stemnion, Inc. | Methods of treating spinal cord injury and minimizing scarring |
| ES2623141T3 (es) * | 2007-01-17 | 2017-07-10 | Noveome Biotherapeutics, Inc. | Nuevos métodos para modular respuestas inflamatorias y/o inmunitarias |
| US20110129544A1 (en) * | 2007-02-22 | 2011-06-02 | Tatsuya Miyazaki | Bone/Cartilage Formation-Stimulation Agent |
| EP2139497B1 (en) * | 2007-04-13 | 2013-11-06 | Stemnion, INC. | Methods for treating nervous system injury and disease |
| US20080279825A1 (en) * | 2007-05-10 | 2008-11-13 | Malinin Theodore I | Cartilage material |
| US20090054339A1 (en) * | 2007-08-22 | 2009-02-26 | Marshall Vivienne S | Novel cellular factor-containing solution compositions |
| WO2010012025A1 (en) * | 2008-07-28 | 2010-02-04 | Monash University | Amnion epithelial cells for the treatment of degenerative disc disease |
| US20100215731A1 (en) * | 2009-02-20 | 2010-08-26 | Maastricht University | Method for improving cartilage repair and/or preventing cartilage degeneration in a joint |
-
2012
- 2012-01-07 US US13/374,674 patent/US8642547B2/en active Active
- 2012-01-07 WO PCT/US2012/000017 patent/WO2012096796A1/en not_active Ceased
- 2012-01-07 JP JP2013548446A patent/JP6041812B2/ja active Active
- 2012-01-07 EP EP12734721.9A patent/EP2663637B1/en active Active
- 2012-01-07 CN CN201280004911.0A patent/CN103298927B/zh active Active
- 2012-01-07 CA CA2823689A patent/CA2823689C/en active Active
- 2012-01-07 ES ES12734721.9T patent/ES2646438T3/es active Active
-
2013
- 2013-03-05 US US13/785,139 patent/US8883136B2/en active Active
-
2014
- 2014-10-28 US US14/525,654 patent/US9623089B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12013501791B1 (en) | Uses of dpp-iv inhibitors | |
| MX2021004546A (es) | Composiciones de suministro de farmaco implantables y metodos de uso de las mismas. | |
| WO2013123215A3 (en) | Antiviral drugs for treatment of arenavirus infection | |
| JP2010507567A5 (https=) | ||
| JP2016508134A5 (https=) | ||
| JP2012041342A5 (https=) | ||
| BR112014019431A8 (pt) | Método compartimentalizado de distribuição de ácido nucleico e composições e usos desses | |
| MX2009008228A (es) | N-adamantil benzamidas como inhibidores de la dehidrogenasa 11-beta-hidroxiesteroide. | |
| JP2013516482A5 (https=) | ||
| IL216741A (en) | History of imidazolidine-2-van 1,3-imaging modalities as 17-cyp inhibitors, pharmaceutical preparations containing them, and their use in the preparation of drugs for the treatment of diseases | |
| MX2010002278A (es) | Farmacos antivirales para el tratamiento de una infeccion por arenavirus. | |
| JP2016517888A5 (https=) | ||
| JP2013508269A5 (https=) | ||
| WO2008151040A3 (en) | Analgesic coated medical product | |
| JP2012107063A5 (https=) | ||
| JP2014501778A5 (https=) | ||
| BR112017018209A2 (pt) | produtos terapêuticos de polipeptídeo e usos dos mesmos | |
| CN105726513A (zh) | 一种远红外消炎镇痛贴 | |
| JP2015044878A5 (https=) | ||
| JP2014501242A5 (https=) | ||
| BR112014005966A2 (pt) | composições para o tratamento de úlceras periféricas de várias origens | |
| Elliot et al. | Therapeutic benefits of exosomes derived from mesenchymal stromal cells in bleomycin-induced pulmonary fibrosis in aged mice | |
| WO2015060702A8 (en) | Pharmaceutical composition for controlling body mass gain comprising s-phenotropil | |
| WO2015027669A3 (zh) | 苯基取代化合物及其药物组合物和应用 | |
| WO2011052919A3 (ko) | 신규 알파-갈락토실세라마이드 유도체, 이의 약학적으로 허용 가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 면역보조용 약학적 조성물 |